People First

When Professor Chak-sing Lau, Daniel C K Yu Professor in Rheumatology and Clinical Immunology, was a young doctor in the UK in the late 1980s deciding what to specialise in, he was steered towards the emerging field of rheumatology. It turned out to be a fortuitous...

Tried and Tested

Big pharma have been coming to the HKU-CTC for years to test new drugs, either to meet FDA requirements (multi-centre clinical trials must be conducted on patients from different parts of the world to gain approval) or to test new treatments for diseases that are...

Taking the Strain

The discovery is the result of a collaboration between HKUMed and the Shenzhen Institute of Advanced Technology (SIAT), and originated from introducing the concept of ‘antigenic distance’ and ‘antigen field’ to select the optimal booster vaccine seed strain.“The...

Measure of the Mutations

The innovative platform was developed by a cross-disciplinary team comprising researchers from the Faculties of Medicine and Engineering, and uses novel screening methods and advanced genetic techniques to identify the specific genetic and cellular factors responsible...

Better Access to Better Drugs

Warfarin is a standard drug in Hong Kong to prevent blood clots in patients with atrial fibrillation. But it is not easy to use. Patients need to monitor their kidney function and regularly return to the clinic for checks. Yet, there are alternative drugs that do not...